Data / Form D filings / KINEMED INC
KINEMED INC: Form D filings
KINEMED INC, a biotechnology company in Emeryville, CA, filed 10 Form D notices with the SEC between 2009 and 2015. The latest, on July 24, 2015, reports $2.1 million sold of a $12.5 million offering to 40 investors.
Find out what KINEMED INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5980 HORTON STREET, #470, Emeryville, CA, 94608
- Phone
- (510) 655-6525
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1167058
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 24, 2015 | Amendment | $12,500,000 | $2,149,235 | $10,350,765 | 40 | Jun 11, 2015 | sec.gov |
| Jun 26, 2015 | New notice | $12,500,000 | $1,699,235 | $10,800,765 | 32 | Jun 11, 2015 | sec.gov |
| Jan 13, 2014 | Amendment | $8,400,004 | $8,400,004 | $0 | 131 | Aug 20, 2013 | sec.gov |
| Aug 22, 2013 | New notice | $8,400,000 | $1,957,717 | $6,442,283 | 43 | Aug 20, 2013 | sec.gov |
| Dec 13, 2012 | New notice | $5,000,000 | $1,039,850 | $3,960,150 | 25 | Dec 3, 2012 | sec.gov |
| Nov 10, 2011 | Amendment | $6,250,000 | $3,750,000 | $2,500,000 | 78 | Oct 21, 2010 | sec.gov |
| Sep 2, 2011 | New notice | $3,000,000 | $1,815,346 | $1,184,654 | 56 | Oct 21, 2010 | sec.gov |
| Jan 8, 2010 | Amendment | $7,500,000 | $5,547,786 | $1,952,214 | 127 | Aug 18, 2009 | sec.gov |
| Nov 23, 2009 | Amendment | $7,500,000 | $4,746,020 | $2,753,980 | 121 | Aug 18, 2009 | sec.gov |
| Sep 2, 2009 | New notice | $7,500,000 | $4,207,520 | $3,292,480 | 113 | Aug 18, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Patrick J. Doyle | Executive Officer, Director | |
| Matthew M Loar | Executive Officer | |
| K. Peter K Hirth | Director | |
| David M Fineman | Executive Officer, Director | |
| Robert K Curry | Director | |
| James S.J. Manuso | Director | |
| Charles J. Casamento | Director | |
| Marc M Hellerstein | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Jul 20, 2015 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what KINEMED INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.